|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
76,182,000 |
Market
Cap: |
13.21(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$127.77 - $330.23 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 882 |
Guru Rank Value : 0.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System and the Omnipod DASH Insulin Management System, its digital mobile Omnipod platform. The Omnipod System features: a small, self-adhesive disposable tubeless Omnipod device (Pod) that the user fills with insulin and wears directly on the body; and the Personal Diabetes Manager, a wireless, handheld device that programs the Pod with the user's personalized insulin-delivery instructions and, wirelessly monitors the Pod's operation.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,551 |
8,851 |
Total Buy Value |
$0 |
$0 |
$1,006,995 |
$2,012,670 |
Total People Bought |
0 |
0 |
2 |
3 |
Total Buy Transactions |
0 |
0 |
2 |
3 |
Total Shares Sold |
3,660 |
15,341 |
51,904 |
164,922 |
Total Sell Value |
$662,699 |
$2,568,947 |
$8,774,318 |
$39,699,166 |
Total People Sold |
2 |
3 |
5 |
8 |
Total Sell Transactions |
2 |
4 |
8 |
21 |
End Date |
2024-03-09 |
2023-12-07 |
2023-06-08 |
2022-06-08 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Diehl R Anthony |
Secretary and General Counsel |
|
2014-04-03 |
4 |
AS |
$48.69 |
$163,941 |
D/D |
(3,367) |
53,246 |
|
- |
|
Diehl R Anthony |
Secretary and General Counsel |
|
2014-04-02 |
4 |
AS |
$48.63 |
$60,788 |
D/D |
(1,250) |
56,613 |
|
- |
|
Diehl R Anthony |
Secretary and General Counsel |
|
2014-04-02 |
4 |
OE |
$19.14 |
$23,925 |
D/D |
1,250 |
57,863 |
|
- |
|
Desisto Duane |
President and CEO |
|
2014-04-01 |
4 |
AS |
$47.68 |
$953,660 |
D/D |
(20,000) |
257,184 |
|
- |
|
Desisto Duane |
President and CEO |
|
2014-04-01 |
4 |
OE |
$6.83 |
$136,600 |
D/D |
20,000 |
277,184 |
|
- |
|
Desisto Duane |
President and CEO |
|
2014-04-01 |
4 |
D |
$48.31 |
$399,475 |
D/D |
(8,269) |
257,184 |
|
- |
|
Roberts Brian K |
Chief Financial Officer |
|
2014-04-01 |
4 |
D |
$48.31 |
$142,708 |
D/D |
(2,954) |
120,050 |
|
- |
|
Liamos Charles T |
Director |
|
2014-04-01 |
4 |
D |
$48.31 |
$198,119 |
D/D |
(4,101) |
96,733 |
|
- |
|
Diehl R Anthony |
Secretary and General Counsel |
|
2014-04-01 |
4 |
D |
$48.31 |
$78,890 |
D/D |
(1,633) |
56,613 |
|
- |
|
Devlin Peter |
Chief Commercial Officer |
|
2014-04-01 |
4 |
D |
$48.31 |
$125,558 |
D/D |
(2,599) |
79,668 |
|
- |
|
Diehl R Anthony |
Secretary and General Counsel |
|
2014-03-06 |
4 |
AS |
$49.09 |
$613,869 |
D/D |
(12,458) |
58,246 |
|
- |
|
Diehl R Anthony |
Secretary and General Counsel |
|
2014-03-06 |
4 |
OE |
$17.49 |
$75,501 |
D/D |
3,680 |
70,704 |
|
- |
|
Wielinski Tracey Haas |
VP, Global Regulatory, CA, QA |
|
2014-03-06 |
4 |
AS |
$49.10 |
$407,198 |
D/D |
(8,275) |
24,000 |
|
- |
|
Wielinski Tracey Haas |
VP, Global Regulatory, CA, QA |
|
2014-03-06 |
4 |
OE |
$23.27 |
$116,350 |
D/D |
5,000 |
32,275 |
|
- |
|
Desisto Duane |
President and CEO |
|
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
44,000 |
265,453 |
|
- |
|
Desisto Duane |
President and CEO |
|
2014-03-03 |
4 |
AS |
$45.80 |
$916,098 |
D/D |
(20,000) |
221,453 |
|
- |
|
Desisto Duane |
President and CEO |
|
2014-03-03 |
4 |
OE |
$6.83 |
$136,600 |
D/D |
20,000 |
241,453 |
|
- |
|
Devlin Peter |
Chief Commercial Officer |
|
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
82,267 |
|
- |
|
Roberts Brian K |
Chief Financial Officer |
|
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
123,004 |
|
- |
|
Diehl R Anthony |
Secretary and General Counsel |
|
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
67,024 |
|
- |
|
Wielinski Tracey Haas |
VP, Global Regulatory, CA, QA |
|
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
27,275 |
|
- |
|
Liamos Charles T |
Director |
|
2014-03-03 |
4 |
AS |
$45.85 |
$458,465 |
D/D |
(10,000) |
100,834 |
|
- |
|
Liamos Charles T |
Director |
|
2014-03-03 |
4 |
OE |
$15.82 |
$158,200 |
D/D |
10,000 |
110,834 |
|
- |
|
Desisto Duane |
President and CEO |
|
2014-03-01 |
4 |
D |
$47.41 |
$1,082,844 |
D/D |
(22,840) |
221,453 |
|
- |
|
Desisto Duane |
President and CEO |
|
2014-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
244,293 |
|
- |
|
1137 Records found
|
|
Page 29 of 46 |
|
|